Condition

Hematological Neoplasms clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Hematological Neoplasms clinical trials that are recruiting, at sites in 3 countries (most in Tunisia (1), China (1), United States (1)). By phase: Phase 4 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Hematological Neoplasms clinical trials

StudyPhaseWhereStatusRegistered
Virtual reality to distract from pain and anxiety during blood cancer procedures — Tunis, Sfax Governorate Recruiting Jul 25, 2025
Personalized T cells engineered to target TP53 or RAS mutations in blood cancers Phase 1 Bethesda, Maryland Recruiting Apr 1, 2025
Personalized dosing of cancer and infection drugs in children with blood cancers Phase 4 Xuzhou, Jiangsu and 1 other locations Recruiting Feb 18, 2019

All recruiting trials (3)

Related topics

AnxietyBlood CancerMyeloid Leukemia, AcutePain Management

Quick answers

How many Hematological Neoplasms clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in Tunisia (1 trial), China (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 4: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.